Submission Details
| 510(k) Number | K050178 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 26, 2005 |
| Decision Date | June 28, 2005 |
| Days to Decision | 153 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K050178 is an FDA 510(k) clearance for the HBA1C ENZYMATIC ASSAY, a Assay, Glycosylated Hemoglobin (Class II — Special Controls, product code LCP), submitted by General Atomics (San Diego, US). The FDA issued a Cleared decision on June 28, 2005, 153 days after receiving the submission on January 26, 2005. This device falls under the Chemistry review panel. Regulated under 21 CFR 864.7470.
| 510(k) Number | K050178 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 26, 2005 |
| Decision Date | June 28, 2005 |
| Days to Decision | 153 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | LCP — Assay, Glycosylated Hemoglobin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7470 |